Dr Dan Williams, CEO and Co-Founder of new biotech business SynaptixBio, discusses how the search is on to find the first treatment for...

SynaptixBio, an Oxford, UK-based research company, has been launched by a worldwide team of medical and pharmaceutical scientists to...

A new biotech business SynaptixBio has been launched to tackle one of the world’s rarest neurodegenerative diseases. SynaptixBio is...

A biotech business has launched in Oxford in a bid to tackle one of the world’s rarest diseases. SynaptixBio is working to develop a...

A biotech business has launched in Oxford in a bid to tackle one of the world's rarest diseases. SynaptixBio is working to develop a...

A new biotech company has been launched with the goal of taking on one of the world’s rarest neurodegenerative… To continue reading...

Bent Jakobsen, who has previously co-founded three biotech companies abroad, is now helping to establish his fourth of its kind,...

U.K.’s Synaptixbio Ltd. has launched, aiming to tackle a rare and often fatal disease of the central nervous system (CNS), TUBB4a...

A new biotech business has been launched in Oxford to tackle one of the world’s rarest diseases. SynaptixBio is working to develop the...

A team of medical and pharmaceutical experts has founded SynaptixBio, an Oxford-based research company working to develop the world’s...

News round-up by DDW’s Megan Thomas for 18-22 October DDW’s Megan Thomas has selected five stories which highlight the opportunities in...

SynaptixBio CEO and Co-Founder Dan Williams/Courtesy SynaptixBio TUBB4a-related leukodystrophy is considered one of the rarest diseases...